PABLO LUIS
ORTIZ ROMERO
Catedrático de universidad
Columbia University Medical Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Columbia University Medical Center (9)
2024
-
Approach to Mycosis Fungoides in children: Consensus-based recommendations
Journal of the American Academy of Dermatology
-
Maintenance therapy for CTCL: importance for prevention of disease progression
Leukemia and Lymphoma
2023
-
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion (American Journal of Clinical Dermatology, (2023), 24, 1, (5-14), 10.1007/s40257-022-00732-w)
American Journal of Clinical Dermatology
-
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 4, pp. 680-688
-
International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study
Journal of the American Academy of Dermatology, Vol. 88, Núm. 4, pp. 935-937
-
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
American Journal of Clinical Dermatology, Vol. 24, Núm. 1, pp. 5-14
2022
-
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Blood, Vol. 140, Núm. 5, pp. 419-437
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204
2017
-
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
Annals of Oncology, Vol. 28, Núm. 10, pp. 2517-2525